Nuclear AURKA acquires kinase-independent transactivating function to enhance breast cancer stem cell phenotype (2016)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/ncomms10180
PubMed Identifier: 26782714
Publication URI: http://europepmc.org/abstract/MED/26782714
Type: Journal Article/Review
Parent Publication: Nature Communications
Issue: 1
ISSN: 2041-1723